Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
38.77
-1.38 (-3.44%)
Apr 17, 2026, 3:00 PM CST
Mabwell (Shanghai) Bioscience Employees
Mabwell (Shanghai) Bioscience had 1,325 employees as of December 31, 2025. The number of employees decreased by 91 or -6.43% compared to the previous year.
Employees
1,325
Change
-91
Growth
-6.43%
Revenue / Employee
2.21M CNY
Profits / Employee
-3.23M CNY
Market Cap
15.45B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,325 | -91 | -6.43% |
| Jun 30, 2025 | 1,362 | - | - |
| Dec 31, 2024 | 1,416 | -75 | -5.03% |
| Dec 31, 2023 | 1,491 | 439 | 41.73% |
| Jun 30, 2023 | 1,451 | - | - |
| Dec 31, 2022 | 1,052 | 365 | 53.13% |
| Dec 31, 2021 | 687 | 154 | 28.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Chengzhi | 4,295 |
| Tibet Cheezheng Tibetan Medicine | 3,170 |
| Pacific Shuanglin Bio-pharmacy | 2,635 |
| Anhui Anke Biotechnology (Group) | 2,505 |
| Vcanbio Cell & Gene Engineering Corp., | 2,014 |
| Jinyu Bio-technology | 1,740 |
| Inner Mongolia Furui Medical Science | 946 |
| Hualan Biological Vaccine | 748 |